Research Overview
Due to our affiliation with the Department of Clinical Laboratory Medicine, we are conducting research primarily focused on diagnostic and testing aspects within infectious diseases. Our work includes epidemiological surveys of drug resistance using clinical isolates and elucidating new mechanisms of drug resistance. Additionally, under the banner of Digital Microbiology, we are collaborating with industry and academia to develop novel pathogen diagnostic systems utilizing image analysis technology and AI. We are also involved in vaccine-related evaluation research using clinical testing systems.
Key Research Achievements
- Uwamino Y*, Kurafuji T, Takato K, Sakai A, Tanabe A, Noguchi M, Yatabe Y, Arai T, Ohno A, Tomita Y, Shibata A, Yokota H, Yamasawa W, Namkoong H, Sato Y, Hasegawa N, Wakui M, Murata M. Dynamics of Antibody Titers and Cellular Immunity Among Japanese Healthcare Workers During the 6 Months After Receiving Two Doses of BNT162b2 mRNA Vaccine. Vaccine. 2022, 40: 4538-43.
- Uwamino Y*, Nagata M, Aoki W, Fujimori Y, Nakagawa T, Yokota H, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Shiraki T, Uchida S, Uno S, Kabata H, Ikemura S, Kamata H, Ishii M, Fukunaga K, Kawaoka Y, Hasegawa N, Murata M. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2. J Clin Pathol. 2021; 74: 67-8
- Uwamino Y, Kubota H, Sasaki T, Kosaka A, Furuhashi M, Uno S, Kudoh J, Murata M, Hasegawa N. Recovery of FRI-5 carbapenemase at a Japanese hospital where FRI-4 carbapenemase was discovered. J Antimicrob Chemother 2019; 74: 3390-2